Veronika Wirth

Polymyxin B in Combination with Enrofloxacin Exerts Synergistic Killing against Extensively Drug-Resistant Pseudomonas aeruginosa

Jesmin Akter, J. Li, T. Velkov, 2018, Antimicrobial Agents and Chemotherapy.

Generation of anti-idiotype antibodies for application in clinical immunotherapy laboratory analyses.

A. Scott, Zhanqi Liu, T. Johns, 2003, Hybridoma and hybridomics.

APhase I Trial of HumanizedMonoclonal AntibodyA 33 in Patients with Colorectal Carcinoma : Biodistribution , Pharmacokinetics , and QuantitativeTumor Uptake

A. Scott, A. Burgess, A. Papenfuss, 2005 .

Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection Model

J. Li, H. Chan, Yu-Wei Lin, 2017, Antimicrobial Agents and Chemotherapy.

Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients

A. Oliver, C. Landersdorfer, J. Boyce, 2018, Antimicrobial Agents and Chemotherapy.

Phase I Trial of 131I-huA33 in Patients with Advanced Colorectal Carcinoma

Lloyd J. Old, Tim Saunder, Andrew M. Scott, 2005, Clinical Cancer Research.

A Phase I Trial of Humanized Monoclonal Antibody A33 in Patients with Colorectal Carcinoma: Biodistribution, Pharmacokinetics, and Quantitative Tumor Uptake

Robert Jones, Edouard C. Nice, Lloyd J. Old, 2005, Clinical Cancer Research.

Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniae in mouse thigh and lung infection models

Brian T. Tsuji, J. Li, C. Landersdorfer, 2018, The Journal of antimicrobial chemotherapy.